News
Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...
Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a ...
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
17h
inews.co.uk on MSNWeight loss jabs to be given to 3,000 people in trial to get them back into workWeight loss jabs will be given to 3,000 people in a trial to explore whether they can get people back into work, The i Paper ...
Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...
GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.
The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Eli Lilly’s blockbuster GLP-1 drugs dominate headlines, but its broader portfolio deserves a standing ovation for driving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results